Sterneckert, Jared L.
Reinhardt, Peter
Schöler, Hans R.
Article History
First Online: 29 July 2014
Change Date: 8 August 2014
Change Type: Correction
Change Details: In this article, some unintentional mistakes occurred, primarily misnumbered citations. In Table 1, <i>KCNH2</i> gene correction was incorrectly assigned to reference 86 instead of reference 115, <i>LRRK2</i> phenotypes were incorrectly assigned to references 13, 14 and 16 instead of 26, 27 and 29, <i>SMN1</i> gene correction was incorrectly assigned to reference 26 instead of 41, and the cardiomyocyte arrhythmia resulting from <i>CACNA1C</i> mutation (corrected from <i>CACNA1B</i>) was incorrectly assigned to reference 125 instead of 139. Additionally, in Box 3, some of the studies of dopaminergic neuron differentiation were incorrectly assigned to references 13 and 16 instead of 26 and 29. Finally, in the reference list the annotation highlighting work in which genetic correction of a mutation that causes a neurodegenerative disease in patients leads to a phenotypic reversion <i>in vitro</i> was incorrectly assigned to reference 12 instead of references 30, 39–41, 96–98, 123 and 132. The article has been corrected online. The authors apologize for these errors.
Competing interests
: The authors are inventors on a patent application covering smNPCs, which are discussed in this Review.